Scribd Logo
Загрузить

Добро пожаловать в Scribd!

  • Market Research Report: Oncology Pharmaceuticals Market in India

    Загружено:

    Netscribes, Inc.
    163 просмотров9 страниц
    For the complete report, get in touch with us at : info@netscribes.com Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the number of cancer cases, specially in lung cancer and breast cancer cases; changes in the cancer treatment scenario, development of alternative cancer therapies, increased cancer health insurance coverage and increasing amount of foreign direct investment (FDI) is helping the market to grow. The Indian Government, on its part is taking initiatives to work out public-private partnership projects (PPP) and reduce the essential drug prices. The market is expected to exhibit steady growth over the next few years. The report begins with the market overview section which provides an insight into the global market, highlighting the market size and growth. It then moves onto the Indian market, with a focus on market size and growth. It also provides import and export figures of cancer drugs in India in terms of value. Regional break-up of the imports and exports have been included. An analysis of the drivers explains the factors for growth of the industry including increasing cancer cases, changes in the treatment scenario, development of alternative cancer therapies, increasing FDI and increase in the number of cancer health insurances. The key challenges include increased competition, drug patent problems and drug portfolio management problems. The government initiatives section highlights the PPP R&D projects started in the country. It also analyses the various initiatives undertaken to reduce prices of cancer drugs, the various cancer control programmes implemented and the changes in the custom duty structure. A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals. The competition section provides an overview of the competitive landscape in the industry. It includes a brief profile of the major players in the market along with their financials. It also includes the latest developments in the industry.

    Оригинальное название

    Market Research Report : Oncology Pharmaceuticals Market in India

    Авторское право

    © Attribution Non-Commercial (BY-NC)

    Доступные форматы

    PDF, TXT или читайте онлайн в Scribd

    Этот документ был вам полезен?

    Это неприемлемый материал?

    Пожаловаться на этот документ
    For the complete report, get in touch with us at : info@netscribes.com Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the number of cancer cases, specially in lung cancer and breast cancer cases; changes in the cancer treatment scenario, development of alternative cancer therapies, increased cancer health insurance coverage and increasing amount of foreign direct investment (FDI) is helping the market to grow. The Indian Government, on its part is taking initiatives to work out public-private partnership projects (PPP) and reduce the essential drug prices. The market is expected to exhibit steady growth over the next few years. The report begins with the market overview section which provides an insight into the global market, highlighting the market size and growth. It then moves onto the Indian market, with a focus on market size and growth. It also provides import and export figures of cancer drugs in India in terms of value. Regional break-up of the imports and exports have been included. An analysis of the drivers explains the factors for growth of the industry including increasing cancer cases, changes in the treatment scenario, development of alternative cancer therapies, increasing FDI and increase in the number of cancer health insurances. The key challenges include increased competition, drug patent problems and drug portfolio management problems. The government initiatives section highlights the PPP R&D projects started in the country. It also analyses the various initiatives undertaken to reduce prices of cancer drugs, the various cancer control programmes implemented and the changes in the custom duty structure. A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals. The competition section provides an overview of the competitive landscape in the industry. It includes a brief profile of the major players in the market along with their financials. It also includes the latest developments in the industry.

    Авторское право:

    Attribution Non-Commercial (BY-NC)
    Скачайте в формате PDF, TXT или читайте онлайн в Scribd
    Отметить как неприемлемый контент
    163 просмотров9 страниц

    Market Research Report: Oncology Pharmaceuticals Market in India

    Загружено:

    Netscribes, Inc.
    For the complete report, get in touch with us at : info@netscribes.com Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the number of cancer cases, specially in lung cancer and breast cancer cases; changes in the cancer treatment scenario, development of alternative cancer therapies, increased cancer health insurance coverage and increasing amount of foreign direct investment (FDI) is helping the market to grow. The Indian Government, on its part is taking initiatives to work out public-private partnership projects (PPP) and reduce the essential drug prices. The market is expected to exhibit steady growth over the next few years. The report begins with the market overview section which provides an insight into the global market, highlighting the market size and growth. It then moves onto the Indian market, with a focus on market size and growth. It also provides import and export figures of cancer drugs in India in terms of value. Regional break-up of the imports and exports have been included. An analysis of the drivers explains the factors for growth of the industry including increasing cancer cases, changes in the treatment scenario, development of alternative cancer therapies, increasing FDI and increase in the number of cancer health insurances. The key challenges include increased competition, drug patent problems and drug portfolio management problems. The government initiatives section highlights the PPP R&D projects started in the country. It also analyses the various initiatives undertaken to reduce prices of cancer drugs, the various cancer control programmes implemented and the changes in the custom duty structure. A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals. The competition section provides an overview of the competitive landscape in the industry. It includes a brief profile of the major players in the market along with their financials. It also includes the latest developments in the industry.

    Авторское право:

    Attribution Non-Commercial (BY-NC)
    Скачайте в формате PDF, TXT или читайте онлайн в Scribd
    Отметить как неприемлемый контент
    из 9

    Insert Cover Image using Slide Master View Do not distort

    Oncology Pharmaceuticals Market-India


    August 2011

    Executive Summary
    Market
    Oncology pharmaceuticals market in India is valued at INR x bn in 20 Fourth largest in volume, eighth largest in value in the world market Market is expected to grow at a CAGR of y% from20-----

    Drivers:
    Drivers and Challenges
    Increasing number of cancer cases Changes in the treatment scenario Development of alternative cancer therapies Increase in cancer insurances Increase in FDI

    Challenges:

    Government Initiatives Drug regulation and patents

    Reforms in tax structure Reduction in drug prices Public Private Partnership (PPP) programmes Drug control programmes Phases of clinical trial Approval and licensing of drugs Patents

    LE P M A S

    Increased competition Drug patents problem Drug Portfolio management

    Competition

    Highly fragmented market with large number of players Major foreign players in the market include Company 1,Company 2,Company 3etc Major domestic companies include Company 4, Company 5, Company 6, among others

    ONCOLOGY PHARMACEUTICALS MARKET IN INDIA 2011.PPT

    Market Overview Drivers & Challenges Government Initiatives Drug regulation and patents Competition

    ONCOLOGY PHARMACEUTICALS MARKET IN INDIA 2011.PPT

    Indian oncology pharma market has grown enormously over the last few years
    Indian market-overview
    Fourth largest in volume, eighth largest in value in the world market Expected to reach INR y bn in 20-Cancer is the second largest cause of death in the country According to the National Cancer Registry Program (NCRP) there are z mn cancer patients at any point of time X cancer related deaths each year Oral and lung cancer are the most common in males, while in females, cervical, followed by breast and ovarian cancer are the most common Availibilty of xx oncologists per yy people in India
    50 40 30 20 10

    Market size
    INR bn Y% c d e g f

    LE P M A S
    0
    1,200 1,000 800 600 400 200 0

    2010

    2011e

    2012e

    2013e

    2014e

    2015e

    2016e

    Increase in cancer cases


    Z% X Y

    In 000

    2010

    2020e

    Source: ONCOLOGY PHARMACEUTICALS MARKET IN INDIA 2011.PPT

    A huge volume of cancer drugs is exported to many countries


    Exports of oncological pharmaceuticals
    Highly fragmented market with many domestic manufacturers lead to huge volume of exports Exports to more than k countries Country 1 and Country 2 account for the highest exports

    Total Exports
    INR mn
    3,000

    E5 e% E4

    Exports Region wise (2008-09)


    i1 i 12 i2 i11 i10 i9 i8 i7 i6 i5
    Source:

    Country 1 Country 2 Country 3 Country 4 Country 5 Country 6 i3 i4

    E L P M A S
    1,000 0

    2,000

    E3 E2

    E1 2006-07 2007-08 2008-09 2009-10

    2005-06

    Exports Region wise (2009-10)


    Country 1 e7 e1 Country 2 Country 3 Country 4 Country 5 Country 6 e6 e5 e4 e3
    Note: All figures are for financial year

    Country 7 Country 8 Country 9

    Country 10 Country 11 Others e2

    Country 7

    ONCOLOGY PHARMACEUTICALS MARKET IN INDIA 2011.PPT

    Drivers & Challenges

    Drivers
    Increasing number of cancer cases Changes in the treatment scenario Development of alternative cancer therapies Increase in cancer insurances Increase in the amount of FDI

    Challenges
    Increased competition Drug patent problems Drug portfolio management

    ONCOLOGY PHARMACEUTICALS MARKET IN INDIA 2011.PPT

    Government initiatives

    Reforms in tax structure

    Public-Private-partnership (PPP) projects


    Government Initiative

    Cancer control programmes

    Reduction in drug prices

    ONCOLOGY PHARMACEUTICALS MARKET IN INDIA 2011.PPT

    Major domestic players in the market (1/9)


    Company Snapshot: Company 1
    Corporate Information
    Headquarters Founded Products Key People City 1, country 1 19-Product 1, product 2, product 3 Person X, CEO

    Financial Performance
    Revenue INR tn
    3 2 1 0

    Revenue Profit / Loss r2 r1 r3 r4

    Profit INR bn
    2.0 1.5 1.0 0.5 0.0

    Business Highlights

    Has n employees worldwide, with offices in over m countries Operates in India through its subsidiary company 2 Oncology products include Product 1, for treating breast cancer and Product 2 Has recently launched two more cancer drugs in the market- Product 3 and Product 4 Cancer drugs in pipeline include Product 5 in Phase 1 and Product 6 in phase 2 trials Is one of the largest collaborators in the industry with and work with academic institutions ,governments and other pharmaceutical companies to increase R & D

    LE P M A S

    2007

    2008

    2009

    2010

    Source: Company Website; Capital IQ; ONCOLOGY PHARMACEUTICALS MARKET IN INDIA 2011.PPT

    Note: Figures are for year ending 31st December

    Thank you for the attention


    The Oncology Pharmaceuticals Market India report is part of Netscribes Healthcare Industry Series. For more detailed information or customized research requirements please contact:
    Tamojit Roy Phone: +91 33 4064 6215 E-Mail: tamojit.roy@netscribes.com Gagan Uppal Phone: +91 22 4098 7530 E-Mail: gagan.uppal@netscribes.com

    Research on India is a product of Netscribes (India) Pvt. Ltd. Research on India is dedicated to disseminating information and providing quick insights on hot industries in India and other emerging markets. Track our new releases and major updates in these industries on

    About Netscribes Netscribes is a knowledge-consulting and solutions firm with clientele across the globe. The companys expertise spans areas of investment & business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes is a one-stop shop designed to fulfil clients profitability and growth objectives. Disclaimer: This report is published for general information only. Although high standards have been used the preparation, Research on India, Netscribes (India) Pvt. Ltd. or Netscribes is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes (India) Pvt. Ltd. and prior permission is required for guidelines on reproduction.
    ONCOLOGY PHARMACEUTICALS MARKET IN INDIA 2011.PPT

    Вам также может понравиться